These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7432418)

  • 21. Anturane reinfarction trial.
    Evans DW
    Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug reduces incidence of sudden cardiac death.
    Am Fam Physician; 1980 Apr; 21(4):179, 182. PubMed ID: 7377063
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs & dosages: Anturane.
    Occup Health Nurs; 1980 Apr; 28(4):48. PubMed ID: 6987588
    [No Abstract]   [Full Text] [Related]  

  • 26. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease.
    Friedewald WT; Schoenberger JA
    Control Clin Trials; 1982 Sep; 3(3):259-70. PubMed ID: 6129942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.
    Valentine PA; Frew JL; Mashford ML; Sloman JG
    N Engl J Med; 1974 Dec; 291(25):1327-31. PubMed ID: 4610393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
    Foz M
    Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709
    [No Abstract]   [Full Text] [Related]  

  • 31. Sulphinpyrazone in post-myocardial infarction. Report from the Anturan Reinfarction Italian Study.
    Lancet; 1982 Jan; 1(8266):237-42. PubMed ID: 6120272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
    Cairns JA; Gent M; Singer J; Finnie KJ; Froggatt GM; Holder DA; Jablonsky G; Kostuk WJ; Melendez LJ; Myers MG
    N Engl J Med; 1985 Nov; 313(22):1369-75. PubMed ID: 3903504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():4-7. PubMed ID: 6375279
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulphinpyrazone (Anturan) after myocardial infarction.
    Nicholson MR; Whitlock RM
    N Z Med J; 1979 Sep; 90(644):263. PubMed ID: 390442
    [No Abstract]   [Full Text] [Related]  

  • 36. Placebo-controlled, double-blind clinical trials can impede medical progress.
    Ritter JM
    Lancet; 1980 May; 1(8178):1126-7. PubMed ID: 6103452
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulfinpyrazone after myocardial infarction.
    N Engl J Med; 1978 Jun; 298(22):1257-9. PubMed ID: 349383
    [No Abstract]   [Full Text] [Related]  

  • 38. More on sulfinpyrazone after myocardial infarction.
    Hood WB
    N Engl J Med; 1982 Apr; 306(16):988-9. PubMed ID: 7038499
    [No Abstract]   [Full Text] [Related]  

  • 39. Does sulphinpyrazone prevent recurrence of myocardial infarction?
    Lancet; 1982 Mar; 1(8274):735-6. PubMed ID: 6122022
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction.
    Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A
    Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.